Clinical Trial: CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma

Brief Summary: Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.

Detailed Summary:
Sponsor: Emergent BioSolutions

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Emergent BioSolutions

Dates:
Date Received: May 5, 2009
Date Started: May 2007
Date Completion:
Last Updated: February 25, 2013
Last Verified: February 2013